Boc-Lys (Z) -OH (DCHA)

Boc-Lys (Z) -OH (DCHA) is a involves in synthesis thymosin β4, βg and β6 fragments, and increases E-rosette forming capacity in Lupus Nephritis model. Boc-Lys (Z) -OH (DCHA) involves in synthesis Boc-Lyz-OCH3 and acts as a reagent of peptidyl thrombin inhibitors production[1][2][3].

Product Specifications

CAS Number

[16948-04-2]

UNSPSC

12352209

Hazard Statement

H302-H315-H319-H335

Target

Amino Acid Derivatives

Type

Peptides

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/boc-lys-z-oh-dcha.html

Solubility

10 mM in DMSO

Smiles

O=C(O)[C@@H](NC(OC(C)(C)C)=O)CCCCNC(OCC1=CC=CC=C1)=O.C2(NC3CCCCC3)CCCCC2

Molecular Formula

C31H51N3O6

Molecular Weight

561.75

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501

References & Citations

[1]Abiko, et al. Synthesis of six common amino acid sequence fragments of thymosins beta 4, beta 8 and beta 9 and determination of their effects on the low E-rosette forming cells of lupus nephritis patients. Chemical & pharmaceutical bulletin, 1984.|[2]Cal PM, et al. Iminoboronates: a new strategy for reversible protein modification. J Am Chem Soc. 2012 Jun 20;134 (24) :10299-305.|[3]Van Boeckel, et al. Preparation of peptidyl thrombin inhibitors: World Intellectual Property Organization, WO9807308. 1998-02-26.